Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Trends in statin consumption and cardiovascular mortality in Croatia 2004 - 2012 (CROSBI ID 215627)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Vojvodić, Željko ; Štimac, Danijela Trends in statin consumption and cardiovascular mortality in Croatia 2004 - 2012 // Collegium antropologicum, 38 (2014), 2 suppl; 73-78

Podaci o odgovornosti

Vojvodić, Željko ; Štimac, Danijela

engleski

Trends in statin consumption and cardiovascular mortality in Croatia 2004 - 2012

Prescribing of statins showed an increasing trend in all developed countries, during the last two decades. The aim of this study was to research the trends in statins consumption in the period from 2004 to 2012 as well as the trends of cardiovascular mortality during the 1990 to 2012 period, and to compare it between Croatia and several neighbouring countries. Data on statins expenditures and consumption expresed in DDD/TID, were taken from annual reports of Croatian Agency for Medicinal Products and Medical Devices (HALMED). Data on crude Mortality rates and standardized cardiovascular mortality rates, were taken from the Croatian Health Statistics Yearbooks. During the observed period utilization of statins increased by 196, 7% with the highest consumption of atorvastatin and simvastatin. Financial expenditure of statins expanded at much faster rate in comparison with drug costs in total. Cardiovascular mortality rates decreased slightly, while maintaining higher level in comparison with some neighbouring countries.

consumption; statins; cardiovascular mortality

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

38 (2 suppl)

2014.

73-78

objavljeno

0350-6134

Povezanost rada

nije evidentirano

Poveznice
Indeksiranost